5. Lupski JR, Wise CA, Kuwano A, Pentao L, Parke JT, Glaze DG, Ledbetter DH, Greenberg F, Patel PI. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nature Genet 1992; 1: 29-33.

6. Lupski JR. DNA diagnostics for Charcot-Marie-Tooth disease and related inherited neuropathies. Clin Chem 1996; 42: 995-998.

7. Young P, Stogbauer F, Wiebusch H, Lofgren A, Timmerman V, van Broeckhoven C, Ringelstein EB, Assmann G, Funke H. PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A. Neurology 1998; 50: 760-763.

8. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.

9. Chen KL, Wang YL, Rennert H, Joshi I, Mills JK, Leonard DG, Wilson RB. Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy. Am J Med Genet 1999; 85 (5): 463-469.

10. Cudrey C, Chevillard C, Le Paslier D, Vignal A, Passage E, Fontes M. Assignment of microsatellite sequences to the region duplicated in CMT1a (17p12): a useful tool for diagnosis. J Med Genet 1995; 32: 231-233.

11. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Sacedo-Cardenas O, Barker DF, Killian JM, Garcia CA. DNA duplication associated with Charcot-Marie-Tooth type 1A. Cell 1991; 66: 219-239.